Akoya Biosciences Inc (NAS:AKYA)
$ 2.498 -0.052 (-2.04%) Market Cap: 126.39 Mil Enterprise Value: 165.50 Mil PE Ratio: 0 PB Ratio: 9.11 GF Score: 46/100

Akoya Biosciences Inc at Bank of America Healthcare Conference Transcript

May 10, 2022 / 05:40PM GMT
Release Date Price: $9.69 (+15.63%)
Brian McKelligon
Akoya Biosciences, Inc. - President, CEO & Director

Thank you all for joining here. Thank you for all joining online. My name is Brian McKelligon, the CEO of Akoya Biosciences. Maybe before we get started, just the necessary disclaimers. I'd advise you to look at this online for your own review.

So Akoya, I'm thankful to be joined by a really special leadership team. Just I wanted to introduce them before I get into the details. Joe has been a CFO for many public company, a really seasoned executive; Niro, really, I'd argue, kind of one of the leaders in the spatial biology space; Fred, just an operational beast. He did a lot at Genomic Health, getting that ready for the acquisition by Exact Sciences.

Two more recent hires. We hired Dr. El-Gabry. He's a trained surgeon and pathologist, most recently ran the CDX division of Roche. He's going to be really important as we advance our clinical initiatives. And then formally having a Chief People Officer is a really important milestone for us, given our scale.

Just to summarize kind of what we do, we're really

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot